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Abstract
Syncope is a common complaint among patients presenting to the emergency department. Its
differential diagnosis is broad and its management varies significantly depending on the
underlying etiology. This is especially complex in patients with head and neck cancer since it
may appear as an initial manifestation of the disease, as a side effect of surgery or radiotherapy,
or as an indicator of local recurrence. Carotid sinus syndrome is a rare disease, whose
pathophysiology is not yet fully understood. Here, we present the rare case of a 79-year-old
male patient with a left cervical lymph node metastasis from an occult primary malignancy,
who was admitted due to recurrent syncope. Paroxysms of extreme bradycardia were detected
and a definitive dual chamber pacemaker was placed; however, the patient remained
symptomatic. Cervical CT-scan revealed incarceration and compression of the left carotid
sinus. The patient underwent radiotherapy, with favourable response, and remains
asymptomatic to date.
Categories: Cardiology, Internal Medicine, Oncology
Keywords: syncope, carotid sinus, head and neck neoplasms, radiotherapy
Introduction
Transient loss of conscience is a frequent cause of visit to healthcare services [1]. The
differential diagnosis is extensive and includes heart and lung disease, metabolic disorders and
epilepsy.
The carotid sinus integrates, along with the aortic arch bodies, the baroreceptor system,
responsible for homeostasis and maintenance of blood pressure. Carotid sinus reflex receptors
are found in the tunica adventitia and are responsible for generating impulses in response to
arterial wall stretching, which are transmitted by the Hering nerve via the glossopharyngeal
nerve to the solitary tract nucleus. Efferent fibres transmit adrenergic sympathetic innervation
to the heart, resistance and capacitance vessels and vagus nerve, leading to increased
parasympathetic flow, which results in bradycardia and transient arterial hypotension.
Compromise of these neurally mediated mechanisms is a frequent and underdiagnosed cause
of syncope [2].
In patients with head and neck cancer, syncope may appear as an initial manifestation of the
disease, as a side effect of surgery or radiotherapy, or as an indicator of local recurrence [3].
Three syndromes, with distinct pathophysiology, are described in literature: carotid sinus
syndrome (CSS), due to compression or invasion of the carotid sinus, which triggers an
overactive reflex and strong efferent vagal response that may result in sinus bradycardia, sinus
arrest or atrioventricular conduction disturbances; glossopharyngeal-asystole neuralgia
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pharyngeal space syndrome, due to tumoral compression or invasion of the para-pharyngeal
space and stimulation of glossopharyngeal afferent fibres. In addition, baroreceptor reflex
failure syndrome is also described, usually secondary to surgery or radiotherapy.
There is general consensus in the definition of CSS, which reflects symptoms directly resulting
from carotid sinus hypersensitivity (CSH). Although there is no universally accepted definition
of CSH, the most commonly accepted one is presented by the 2017 American College of
Cardiology/American Heart Association/Heart Rhythm Society (ACC/AHA/HRS) and the 2018
European Society of Cardiology (ESC) syncope guidelines, which consider an abnormal value to
be heart rate (HR) pauses >3 seconds and a drop in systolic blood pressure (BP) >50 mmHg [1,4].
These values define the two main subtypes of CSS: cardioinhibitory (70-75% of cases) and
vasodepressor (5-10%), respectively. A mixed subtype, combining both of these findings, may
be present in 20-25% of patients.
CSS presents in older patients, with a mean age of 75 years, and has a strong male dominance
(>2:1). It accounts for 1% of syncope cases [5]. Among these, head and neck tumours are rare
(<1/250) and most cases occur in the presence of extensive cervical lymph node involvement
[6,7]. Treatment depends on the frequency and severity of symptoms. Dual chamber pacing is
most effective in patients with cardioinhibitory CSS and a negative tilt test. Therapy for the
vasodepressor component of CSS, where tilt testing is likely positive, includes anticholinergics,
fludrocortisone, midodrine and other vasopressors, but is often unsatisfactory [8]. Definitive
treatment consists of surgical removal of the tumour. Other surgical methods include carotid
sinus denervation by sectioning of the Hering nerve, arterial adventitial stripping or
intracranial sectioning of the glossopharyngeal nerve and the first two roots of the vagus nerve,
although there is insufficient data to prove the efficacy of these techniques [9].
Case Presentation
A 79-year-old male patient, with smoking habits and arterial hypertension, presented with
mild weight loss and faintness for the past six months. A large left cervical mass was apparent
and computerized tomography (CT) scan of the neck had revealed a large, solid, heterogenous
lesion (47 x 35 mm), with several adjacent adenopathies (Figure 1).
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FIGURE 1: Cervical CT-scan at the time of diagnosis (axial
view)
CT-scan of the thorax, abdomen and pelvis showed an infracentimetric mass (5 mm) in the
posterior segment of the left superior lobe, with no signs of metastasis. Intraoperatively, during
incisional biopsy, infiltration of adjacent structures was observed. Immunohistochemistry was
compatible with lymph node metastasis of a poorly differentiated CK7+/CK20- carcinoma, with
focal marking for thyroid transcription factor 1 (TTF-1), suggestive of primary lung neoplasm.
The disease was staged as cT0N2M0. Although the patient was referred to an Oncology
consultation, follow-up was lost and no treatment was initiated.
Three months later, the patient presented once again due to recurrent syncope in the last
month. He reported sudden episodes of blurry vision and dizziness, with no complaints of chest
pain, dyspnea or palpitations, followed by loss of muscle tone and conscience, usually lasting
less than 15 seconds, with full recovery in a few minutes. No neurologic deficits, orthostatic
hypotension or other specific triggers were apparent. Junctional bradycardia (HR: 40-45 bpm)
was detected, with no elevation of myocardial necrosis markers or electrolyte imbalance.
Transthoracic echocardiography showed no abnormal findings and head-CT revealed only mild
carotid atherosclerosis. Tilt testing was not performed. A diagnosis of sick sinus syndrome was
assumed and a definitive DDDR pacemaker was placed.
One week after discharge, the patient presented once again due to syncope. Physical
examination and blood work remained unchanged. Pacemaker dysfunction was excluded. Soft
tissue CT-scan of the neck was repeated, revealing a significant increase in tumour size (120 x
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72 x 64 mm) and extensive infiltration of the sternocleidomastoid muscle and incarceration of
the carotid bifurcation and internal and external carotid arteries, a finding not present in the
previous study, which dated four months (Figure 2).
FIGURE 2: Cervical CT-scan on readmission, revealing
incarceration of the left carotid sinus
(A) Axial view; (B) coronal view; (C) sagittal view; (D) 3D reconstruction.
Positron emission tomography (PET) scan showed viable neoplastic tissue in the large left
latero-cervical mass, as well as in several other ipsilateral latero-cervical adenopathies in
groups III, IV and V, with no other hypermetabolic activity, namely in the lung, and the tumour
was re-staged as cT0N3M0 (Figure 3).
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FIGURE 3: Positron emission tomography scan
The patient was initiated on simultaneous integrated boost intensity modulated radiotherapy
(SIB-IMRT), completing 33 sessions, with considerable decrease in tumour size (6 x 3 cm)
(Figure 4).
2020 Toscano et al. Cureus 12(2): e7042. DOI 10.7759/cureus.7042 5 of 8
FIGURE 4: Cervical CT-scan after radiotherapy, showing
significant decrease in mass size
(A) Axial view; (B) coronal view; (C) sagittal view.
No further episodes of lipothymia or syncope were noted and the patient remains asymptomatic
to date, after one-year follow-up.
Discussion
We present a case of carotid sinus syndrome due to compression and invasion of the carotid
sinus by a lymph node metastasis of an occult carcinoma, which resulted in recurrent faintness
and syncope. As described in most cases in literature, no precipitating factors were identified in
this patient (i.e., hyperextension of the neck, constrictive clothing around the neck, coughing,
sneezing or shaving).
Interestingly, although stimulation of both carotid sinuses causes a decrease in heart rate, in a
study by Sigler with 345 healthy individuals, a difference in left and right carotid sinus
stimulation was reported, the first being more sensitive to stimulation and more often
associated with high-grade atrioventricular block (Mobitz II and third degree), while the latter
usually results in sinus bradycardia [10]. Asystole was also twice as frequent with right
stimulation when compared with left stimulation. In our case, as a result of compression of the
left carotid sinus, only bradycardia was recorded and atrioventricular block was not observed.
Carotid sinus response to stimulation is higher in men (4:1), as is the degree of heart rate
decrease, especially in patients with atherosclerotic heart disease and hypertension, as in this
case.
No specific therapy is recommended for patients with documented CSH without associated
symptoms. Response to dual chamber pacing depends on the pathophysiology and predominant
causative mechanism, with greater impact in select patients with episodes of asystole or severe
bradycardia. As such, permanent pacemaker placement is indicated in patients with
predominant or pure cardioinhibitory component (ACA/AHA/HRS class I indication; ESC class
Ib indication) [1,4]. Despite this, studies show that 15% of patients have no clinical benefit and
about 50% maintain mild or recurrent symptoms after pacemaker placement [11]. Furthermore,
mixed subtype was associated with a two- to three-fold increase in the risk of symptom
recurrence and several recent studies have shown no benefit in reducing syncope events and
falls in elderly patients, contrary to what some previous small studies had indicated, such as
SAFE PACE [12-14]. Persistence or predominance of the vasodepressor component has been
implicated in these cases, which was also the most likely pathophysiologic mechanism in the
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patient described [15]. Spontaneous resolution has also been reported in rare cases.
It is important to note that, although severe bradycardia and hypotension may be present, the
risk of mortality and cardiovascular events by CSH is not affected [16].
Definitive treatment consists in surgical removal of the tumour responsible for carotid sinus
compression, when possible. Seeing as full surgical resection was not possible, and given the
N3 staging, isolated radiotherapy was the safest option. Cisplatin radiosensitization was not
performed because studies have shown no benefit in patients over 70 years [17,18].
Conclusions
Unexplained syncope should alert the clinician to the possibility of carotid sinus compression,
especially in patients with head and neck cancer. The treatment of recurrent reflex syncope in
these patients is especially complex. Therapeutic options should be individualized according to
the frequency and severity of symptoms and it is important to consider the risks associated
with procedures for prevention of infrequent events.
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